BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/22/2022 2:35:00 PM | Browse: 254 | Download: 426
 |
Received |
|
2021-08-24 12:39 |
|
Peer-Review Started |
|
2021-08-24 12:41 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-17 02:38 |
|
Revised |
|
2021-11-19 03:45 |
|
Second Decision |
|
2022-02-14 05:28 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-02-16 07:00 |
|
Articles in Press |
|
2022-02-16 07:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-02-09 17:39 |
|
Typeset the Manuscript |
|
2022-03-04 22:33 |
|
Publish the Manuscript Online |
|
2022-03-22 14:35 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Retrospective Study |
| Article Title |
Treatment of pneumocystis jirovecii pneumonia in non-human immunodeficiency virus-infected patients using a combination of trimethoprim-sulfamethoxazole and caspofungin
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Huan-Huan Wu, Shuang-Yan Fang, Yan-Xiao Chen and Lan-Fang Feng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Huan-Huan Wu, MD, Doctor, Department of Respiratory Medicine, Dongyang Hospital Affiliated to Wenzhou Medical University, No. 60 Wuning West Road, Dongyang 322100, Zhejiang Province, China. huanhuan871002@163.com |
| Key Words |
Acquired immunodeficiency syndrome; Non-human immunodeficiency virus-infected patients; Immunosuppression; caspofungin; Mortality; Pneumocystis jirovecii pneumonia |
| Core Tip |
Pneumocystis jirovecii pneumonia (PJP) is an infectious disease common in immunocompromised hosts. However, the clinical characteristics of non-human immunodeficiency virus (HIV) infected PJP patients have not been fully elucidated. The current study was a retrospective study of non-HIV-infected PJP treated with trimethoprim-sulfamethoxazole (TMP-SMX) and caspofungin. Clinical manifestations, treatment and prognosis of the patients were evaluated. Non-HIV-infected PJP patients are characterized by rapid disease progression, high risk of respiratory failure, and high mortality. Early diagnosis and treatment can improve survival in non-HIV-infected PJP populations. The findings of the current study showed that a combination of TMP-SMX and caspofungin is an effective therapy for non-HIV-infected PJP patients with respiratory failure. |
| Publish Date |
2022-03-22 14:35 |
| Citation |
Wu HH, Fang SY, Chen YX, Feng LF. Treatment of Pneumocystis jirovecii pneumonia in non-human immunodeficiency virus-infected patients using a combination of trimethoprim-sulfamethoxazole and caspofungin. World J Clin Cases 2022; 10(9): 2743-2750 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i9/2743.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i9.2743 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
